芬太尼类物质研究进展

陈园园; 李香豫; 许鹏飞; 卢晓鵾; 王优美; 徐鹏; 狄斌

doi:10.11665/j.issn.1000-5048.20200612

芬太尼类物质研究进展

陈园园^1,2,
李香豫^2,3,
许鹏飞^2,3,
卢晓鵾^2,3,
王优美^2,3,
徐鹏^2,3,
狄斌^1,2

1.
中国药科大学药学院，南京 210009
2.
国家禁毒委员会办公室中国药科大学禁毒关键技术联合实验室，北京 100193
3.
毒品监测管控与禁毒关键技术公安部重点实验室，公安部禁毒情报技术中心，北京 100193

基金项目: 十三五国家重点研究与发展计划资助项目（No.2017YFC0803605,No.2018YFC0807402）

计量
- 文章访问数: 621
- HTML全文浏览量: 8
- PDF下载量: 1362
出版历程
- 收稿日期: 2019-10-12
- 修回日期: 2020-10-12
- 刊出日期: 2020-12-24

Research advances of fentanyl and fentanyl-related substances

Chen Yuanyuan^1,2,
Li Xiangyu^2,3,
XU Pengfei^2,3,
LU Xiaokun^2,3,
WANG Youmei^2,3,
XU Peng^2,3,
DI Bin^1,2

Funds: This study was supported by the National Key Research and Development Program of China for the 13th Five-Year Plan (No.2017YFC0803605,No.2018YFC0807402)

摘要

摘要: 芬太尼类物质是以芬太尼为代表的一类人工合成的强效麻醉剂，近年来在全球多个国家中的滥用和贩卖形势较为严峻，极大威胁人们的健康和社会的安定。通过对芬太尼类物质的滥用、药理毒理作用、检测方法及管控情况等方面进行综述，提高人们对其基本性质、研究现状以及管控情况等方面的了解，为今后的研究提供参考。
- 芬太尼 /
- 芬太尼类物质 /
- 药物滥用 /
- 药理毒理作用 /
- 检测方法 /
- 毒品管控
Abstract: Fentanyl and fentanyl-related substances are a series of synthetic and powerful anesthetics represented by fentanyl. In recent years,the abuse and trafficking of these substances in many countries around the world are serious which poses a great threat to people"s health and social stability. This paper focuses on the abuse,pharmacological and toxicological action,detection methods and control of fentanyl and fentanyl-related substances and aims to enhance people"s understanding of their basic properties,current research and control so as to provide references for future research.
- fentanyl /
- fentanyl-related substances /
- drug abuse /
- pharmacological and toxicological action /
- detection methods /
- narcotics control

HTML全文

参考文献(54)

[1]	. J Beijing Police College（北京警察学院学报），2019（3）：109?115.
[2]	Yang LH. Reflection on the management of the whole class of fentanyl substances in China［J］. J Yunnan Police Officer Academy（云南警官学院学报），2019（4）：1?4.
[3]	Liu ZM. Abuse and control of fentanyl and its derivatives：hazards and challenges［J］. Chin J Drug Depend（中国药物依赖性杂志），2017，26（4）：274?276.
[4]	UNODC. Fentanyl and its anolognes-50 year on［J］. Global SMART Update，2017，17：3?8.
[5]	Karila L，Marillier M，Chaumette B，et al. New synthetic opioids：part of a new addiction landscape［J］. Neurosci Biobehav Rev，2019，106：133?140.
[6]	Baumann MH，Pasternak GW. Novel synthetic opioids and overdose deaths：tip of the iceberg［J］？ Neuropsychopharmacology，2018，43（1）：216?217.
[7]	UNODC. Understanding the global opioid crisis［J］. Global SMART Update，2019，21：6?9.
[8]	Burns SM，Cunningham CW，Mercer SL. DARK classics in chemical neuroscience：fentanyl［J］. ACS Chem Neurosci，2018，9（10）：2428?2437.
[9]	Comer SD，Cahill CM. Fentanyl：receptor pharmacology，abuse potential，and implications for treatment［J］. Neurosci Biobehav Rev，2019，106：49?57.
[10]	Xiao JZ. Pharmacology and clinical practice of remifentanil［J］. J Med Theor Pract （医学理论与实践），2009，22（2）：158?160.
[11]	Yang S，Xu Q. Research progress in the fentanyl and its derivatives in the treatment of cancer pain［J］. Shanghai Med Pharm J（上海医药），2015（5）：32?36.
[12]	Pacifici GM. Clinical pharmacology of fentanyl in preterm infants. A review［J］. Pediatr Neonatol，2015，56（3）：143?148.
[13]	Schaefer CP，Tome ME，Davis TP. The opioid epidemic：a central role for the blood brain barrier in opioid analgesia and abuse［J］. Fluids Barriers CNS，2017，14（1）：32.
[14]	Ninkovi? J，Roy S. Role of the mu-opioid receptor in opioid modulation of immune function［J］. Amino Acids，2013，45（1）：9?24.
[15]	Xu L，Li YH. Studies on pharmacological action and clinical application of sufentanil［J］. Anhui Med Pharm J（安徽医药），2011（3）：375?377.
[16]	Xiao GF，Lv H. Observation on the analgesic effect and stress state of brachial plexus block combined with remifentanil during replantation of severed fingers［J］. J Logist Univ PAPF（武警后勤学院学报），2018，27（6）：48?51.
[17]	Ma L，Wang XL. Evaluation of sufentanil in intravenous postoperative analgesia and clinical anesthesia［J］. Gen J Stomat（全科口腔医学杂志），2018，5（32）：191?192.
[18]	Dumas EO，Pollack GM. Opioid tolerance development：a pharmacokinetic/pharmacodynamic perspective［J］. AAPS J，2008，10（4）：537?551.
[19]	Sutou I，Nakatani T，Hashimoto T，et al. Fentanyl tolerance in the treatment of cancer pain：a case of successful opioid switching from fentanyl to oxycodone at a reduced equivalent dose［J］. J Pain Palliat Care Pharmacother，2015，29（2）：161?165.
[20]	Neunhoeffer F，Hanser A，Esslinger M，et al. Ketamine infusion as a counter measure for opioid tolerance in mechanically ventilated children：a pilot study［J］. Paediatr Drugs，2017，19（3）：259?265.
[21]	Volkow ND，Jones EB，Einstein EB，et al. Prevention and treatment of opioid misuse and addiction：a review［J］. JAMA Psychiatry，2019，76（2）：208?216.
[22]	Hao W，Zhao M，Li J. Addication medicine：theory and practice（成瘾医学：理论和实践）［M］. Beijing：People''''s Medical Publishing House，2016：14?71.
[23]	Aceto M. Dependence studies of new compounds in the rhesus monkey，rat and mouse［J］. Problems Drug Dependence ，1996，1998：338.
[24]	Pan LS，Cui YY，Ren YH，et al. Dependence -producing potential of remifentanil［J］. Chin J Drug Depend（中国药物依赖性杂志），2002，11（2）：107?110.
[25]	Bekhit MH. Opioid-induced hyperalgesia and tolerance［J］. Am J Ther，2010，17（5）：498?510.
[26]	YueK，WenRJ. Neuroimmune mechanism of opiates addiction［J］. J Jianghan Univ（Nat Sci Ed.）［江汉大学学报（自然科学版）］，2017，45（3）：241?246.
[27]	Essawi MY. Fentanyl analogues with a modified propanamido group as potential affinity labels：synthesis and in vivo activity［J］. Pharmazie，1999，54（4）：307?308.
[28]	Lin H，Higgins P，Loh HH，et al. Bidirectional effects of fentanyl on dendritic spines and AMPA receptors depend upon the internalization of mu opioid receptors［J］. Neuropsychopharmacology，2009，34（9）：2097?2111.
[29]	Wei X，Wei W. Role of gabapentin in preventing fentanyl-and morphine-withdrawal-induced hyperalgesia in rats［J］. J Anesth，2012，26（2）：236?241.
[30]	Dolinak D. Opioid toxicity［J］. Acad Forensic Pathol，2017，7（1）：19?35.
[31]	Liu C，Kang Y. How to evaluate and select sedatives and analgesics considering their cardiovascular and respiratory effects［J］？ Chin J Crit Care Intensive Care Med Electron Ed（中华重症医学电子杂志），2017，3（4）：291?295.
[32]	Liu XB，Xu GP. Research progress of mechanism about remifentanil slowing down heart rate［J］. Med Recap（医学综述），2012，18（23）：4027?4029.
[33]	Chen L，Zhao YH，Liu XL. Progress in the application of sufentanil in the treatment of cancer pain［J］. Chin J Pain Med（中国疼痛医学杂志），2018，24（11）：65?68.
[34]	Guo ZF. Clinical application of sufentanil［J］. J Chengde Med Col（承德医学院学报），2016，33（6）：516?519.
[35]	Qian ZH，Li P，Zheng H，et al. Mass fragmentation characteristics of fentanyl analogue［J］. J Chin Mass Spectrom Soc（质谱学报），2018，39（5）：79?88.
[36]	Gupta PK，Yadav SK，Bhutia YD，et al. Synthesis and comparative bioefficacy of N-（1-phenethyl-4-piperidinyl）propionanilide （fentanyl） and its 1-substituted analogs in Swiss albino mice［J］. Med Chem Res，2013，22（8）：3888?3896.
[37]	Swaminathan SK，Fisher J，Kandimalla KK. Sensitive determination of fentanyl in low-volume serum samples by LC-MS/MS［J］. AAPS Pharmscitech，2018，19（7）：2812?2817.
[38]	Mochizuki A，Nakazawa H，Adachi N，et al. Identification and quantification of mepirapim and acetyl fentanyl in authentic human whole blood and urine samples by GC-MS/MS and LC-MS/MS［J］. Forensic Toxicol，2018，36（1）：81?87.
[39]	Misailidi N，Athanaselis S，Nikolaou P，et al. A GC-MS method for the determination of furanylfentanyl and ocfentanil in whole blood with full validation［J］. Forensic Toxicol，2019，37（1）：238?244.
[40]	Liu CM. The application prospect of fourier transform infrared spectroscopy in narcotics control area［J］. Spectrosc Spectral Anal（光谱学与光谱分析），2018，38（S1）：400?401.
[41]	Mallette JR，Casale JF，Toske SG，et al. Characterization of （2R，4S）- and （2R，4R）-2-Methylfentanyl and their differentiation from cis- and trans-3-methylfentanyl［J］. Forensic Chem，2018，8：64?71.
[42]	Li KK，Miao CY，Wang DK. Detection of drugs by raman spectroscopy and data analysis based on R software［J］. J Light Scat （光散射学报），2018，30（2）：156?162.
[43]	Kong LC，Zuo GM，Liu GQ，et al. Surface-enhanced raman spectroscopy for trace fentanyl detection in water［J］. J Light Scat （光散射学报），2010，22（1）：34?38.
[44]	Tiscione NB，Wegner K. Validation of the Neogen^?Fentanyl ELISA kit for blood and urine［J］. J Anal Toxicol，2017，41（4）：313?317.
[45]	Smith JS，Mochel JP，Borts DJ，et al. Adverse reactions to fentanyl transdermal patches in calves：a preliminary clinical and pharmacokinetic study［J］. Vet Anaesth Analg，2018，45（4）：575?580.
[46]	Wan HN. Application and development of immunoassay in drug testing and identification［J］. J Liaoning Police Coll（辽宁警察学院学报），2018，20（2）：65?69.
[47]	Center For Medical Device Evaluation. NMPA. Notice of issuance of registered designated inspection notice on 30 August，2019［EB/OL］.（2019-08-30）［2019-09-12］.https：//www.cmde.org.cn/CL0151/19680.html.
[48]	Zaknoun H，Binette MJ，Tam M. Analyzing fentanyl and fentanyl analogues by ion mob spectrometry［J］. Int J Ion Mobil Spectrom，2019，22（1）：1?10.
[49]	UNODC. Recommended methods for the identification and analysis of fentanyl and its analogues in biological specimens：manual for use by national drug analysis laboratories［EB/OL］. （2017-12-07）［2019-11-11］.www.unodc.org/documents/scientific/Recommended_methods_for_the_identification_and_analysis_of_fentanyl.pdf.
[50]	Zhang WY，Lin JF，Yan J，et al. Rapid screening of fentanyl substances and their precursors without the standards［J］. J Anal Sci（分析科学学报），2019，35（5）：635?642.
[51]	United States Drug Enforcement Administration. Schedules of controlled substances：temporary placement of fentanyl-related substances in schedule I［EB/OL］. （2018-02-06）［2019-11-11］. https：//www.deadiversion.usdoj.gov/fed_regs/rules/2018/fr0206_4.htm.
[52]	EMCDDA. Fentanils and synthetic cannabinoids：driving greater complexity into the drug situation-An update from the EU Early Warning System［EB/OL］. （2018-06-01）［2019-11-11］. http：//www.emcdda.europa.eu/publications/rapid-communications/fentanils-and-synthetic-cannabinoids-ews-update_en.
[53]	Supreme people''''s court. Notice on the issuance of the catalogue of varieties of narcotic drugs and the catalogue of psychotropic drugs［EB/OL］. （2019-11-11）［2019-11-11］. http：//www.qlgl.gov.cn/show-20-5239-1.html.
[54]	China National Narcotic Control Commision. China conducts the management of four fentanyl substances such as carfentanil［EB/OL］. （2017-02-16）［2019-11-11］. http：//www.nncc626.com/2017-02/16/c_129482280_5.htm.